A new research report entitled “US Healthcare Market Outlook 2013”,
from RNCOS says that the drug spending has increased at a significant rate and is responsible for major healthcare spending in the US. Pharmaceutical drugs are in prolific demand in the country owing to high prevalence of chronic diseases, increased purchasing ability, and preference of branded drugs. Moreover, high prices of drugs in the US are also likely to fuel drug-related expenditures further.
The generic drug market is expected to soar in the country in the coming years. According to our report spread in over 80 pages, the low cost of generics in the market are causing a steady rise in the number of generic drug prescriptions dispensed in the market. Healthcare spending in the country is high and is expected to grow further at a CAGR of around 5% during 2010-2013.
The report provides an in-depth research and rational analysis of the current status and expected position of the healthcare market in the US. It also entails future forecasts on the healthcare-related expenditures among other forecasts for market segments, such as medical device market and healthcare-IT market. Further, the report provides a prudent analysis on the various sub-segments of the industry and their performances. The regulatory environment plays a central role in the country’s healthcare performance. The report elaborates on the regulatory scenario in the country and describes the impact of recent reforms on the industry sub-segments. It also offers information on the several challenges that are required to be addressed. In-depth knowledge about the major competitors in the healthcare segment is also covered in the report. Overall, the report suffices in presenting an unbiased analysis and a holistic understanding to the reader.
Some of our Related Reports are as follows: